An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.
Experimental Treatment Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and claims of next-day UK delivery. Sellers market the drug there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Worries
Nevertheless, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.
Several professionals said the popularity for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.
Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.
Platform Reaction and Material Removal
According to the social media company, the service has taken down violative content and banned associated hashtags and search suggestions. The company said it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Online Marketplace Activities
Investigations also found groups with up to nine thousand participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, filled with photos of slimming results, glowing testimonials and detailed instructions for preparing or injecting at home.
Within minutes of joining one community, a seller shared WhatsApp details, where most transactions occur. The seller sent an guidebook and promised shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience.
Product Information and Pricing
Inside these groups, messages show dark colored parcels with Royal Mail labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how long a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for the messaging service stated it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering materials they can’t verify. Although the research behind retatrutide is valid, these digital versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her staff has previously encountered patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to potentially serious medical dangers”.
